One of the most advanced Insulin Pump on the market (as of November 2015), the MiniMed® 640G System features smart technology that closely mimics the way a healthy pancreas delivers basal insulin to the body – giving your patients better control over diabetes.
TECHNOLOGY THAT TRANSFORMS LIVES
Transforming diabetes care to give patients freedom from the disease may appear to be an ambitious goal. But it’s something that, working closely with our partners, we are absolutely focused on delivering: to go Further Together in bringing the latest technology to people with diabetes. Taking Diabetes Management to the next level. Today, we continue to create meaningful innovations beyond pumps and sensors, by integrating leading consumer technologies, data and informatics, to enable better therapy decision-making and care for people with both Type 1 and Type 2 diabetes.
Continuous Glucose Monitoring (CGM)
Our unique CGM system allows patients to continuously monitor their glucose levels – helping them discerning distinct patterns of abnormal glycaemia1. When used with the MiniMed® 640G, Continuous Glucose Monitoring values can also cause an insulin pump to suspend insulin delivery to help prevent hypoglycaemia.
We offer a wide range of infusion sets to ensure your patient’s comfort and safety. The choice of infusion set should be based on the patient’s lifestyle, age, body build and clinical recommendations.
Blood Glucose Meter
CareLink - Data Management Software
CareLink® is a secure, web-based therapy management software for patients and healthcare professionals. With CareLink® Personal, patients can send data from their MiniMed® 640G System^ and blood glucose meter, while CareLink® Pro contains adherence notes.
iPro2 Continuous Glucose Monitoring (CGM)
The only available Continuous Glucose Monitoring device specifically designed for professional use. Used for the ‘masked’ collection of glucose data, it provides unbiased results and returns critical glucose level information to help you make informed treatment decisions with your diabetes patients.
i-Port Advance insulin device
This product is designed to accommodate multiple injections without the discomfort of additional needle sticks. Rather than numerous daily injections, the subcutaneous injection port allows insulin administration for up to 72 hours.